Teza Capital Management LLC Acquires New Holdings in Bath & Body Works, Inc. (NYSE:BBWI)

Teza Capital Management LLC acquired a new position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 8,675 shares of the company's stock, valued at approximately $336,000.

Other large investors have also modified their holdings of the company. Golden State Wealth Management LLC purchased a new position in shares of Bath & Body Works in the 4th quarter valued at about $26,000. SRS Capital Advisors Inc. grew its holdings in Bath & Body Works by 99.7% in the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock valued at $26,000 after purchasing an additional 329 shares during the period. UMB Bank n.a. grew its holdings in Bath & Body Works by 58.8% in the fourth quarter. UMB Bank n.a. now owns 905 shares of the company's stock valued at $35,000 after purchasing an additional 335 shares during the period. Lindbrook Capital LLC increased its position in shares of Bath & Body Works by 81.9% in the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock valued at $37,000 after buying an additional 431 shares in the last quarter. Finally, Smartleaf Asset Management LLC increased its position in shares of Bath & Body Works by 135.0% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,013 shares of the company's stock valued at $39,000 after buying an additional 582 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company's stock.

Bath & Body Works Stock Performance

Shares of BBWI stock traded down $1.11 during trading hours on Monday, reaching $30.27. The company had a trading volume of 4,248,822 shares, compared to its average volume of 4,904,326. Bath & Body Works, Inc. has a 12-month low of $24.96 and a 12-month high of $52.99. The company has a market capitalization of $6.45 billion, a price-to-earnings ratio of 7.38, a PEG ratio of 0.92 and a beta of 1.87. The stock has a fifty day moving average of $30.22 and a 200-day moving average of $34.03.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings data on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, topping analysts' consensus estimates of $2.04 by $0.05. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The company had revenue of $2.79 billion for the quarter, compared to analyst estimates of $2.78 billion. On average, analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works declared that its board has authorized a stock repurchase plan on Thursday, February 27th that permits the company to repurchase $500.00 million in outstanding shares. This repurchase authorization permits the company to purchase up to 6.4% of its stock through open market purchases. Stock repurchase plans are often a sign that the company's board of directors believes its stock is undervalued.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 20th. Investors of record on Friday, June 6th will be given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 2.64%. The ex-dividend date of this dividend is Friday, June 6th. Bath & Body Works's payout ratio is currently 21.98%.

Wall Street Analyst Weigh In

BBWI has been the topic of a number of research analyst reports. Citigroup lifted their price target on shares of Bath & Body Works from $36.00 to $42.00 and gave the company a "buy" rating in a research note on Tuesday, May 20th. Robert W. Baird increased their price objective on shares of Bath & Body Works from $45.00 to $47.00 and gave the company an "outperform" rating in a report on Friday, February 28th. JPMorgan Chase & Co. boosted their target price on shares of Bath & Body Works from $41.00 to $43.00 and gave the stock an "overweight" rating in a research note on Monday, May 19th. Telsey Advisory Group restated an "outperform" rating and set a $43.00 price target on shares of Bath & Body Works in a research report on Tuesday, May 20th. Finally, The Goldman Sachs Group decreased their price target on shares of Bath & Body Works from $49.00 to $42.00 and set a "buy" rating on the stock in a research note on Tuesday, April 22nd. Four research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $42.56.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.